- Home
- YI vs CNTB Comparison
YI vs CNTB Comparison
Compare YI & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YI
- CNTB
- Stock Information
- Founded
- YI 2010
- CNTB 2012
- Country
- YI China
- CNTB United States
- Employees
- YI N/A
- CNTB N/A
- Industry
- YI Retail-Drug Stores and Proprietary Stores
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- YI Consumer Staples
- CNTB Health Care
- Exchange
- YI Nasdaq
- CNTB Nasdaq
- Market Cap
- YI 68.5M
- CNTB 55.2M
- IPO Year
- YI N/A
- CNTB 2021
- Fundamental
- Price
- YI $8.26
- CNTB $0.78
- Analyst Decision
- YI
- CNTB Strong Buy
- Analyst Count
- YI 0
- CNTB 1
- Target Price
- YI N/A
- CNTB $8.00
- AVG Volume (30 Days)
- YI 46.0K
- CNTB 15.9K
- Earning Date
- YI 03-20-2025
- CNTB 04-15-2025
- Dividend Yield
- YI N/A
- CNTB N/A
- EPS Growth
- YI N/A
- CNTB N/A
- EPS
- YI N/A
- CNTB N/A
- Revenue
- YI $2,090,255,896.00
- CNTB $24,116,000.00
- Revenue This Year
- YI $61.85
- CNTB N/A
- Revenue Next Year
- YI N/A
- CNTB $63.90
- P/E Ratio
- YI N/A
- CNTB N/A
- Revenue Growth
- YI N/A
- CNTB N/A
- 52 Week Low
- YI $0.41
- CNTB $0.86
- 52 Week High
- YI $8.81
- CNTB $2.66
- Technical
- Relative Strength Index (RSI)
- YI 87.81
- CNTB 36.46
- Support Level
- YI $6.88
- CNTB $0.91
- Resistance Level
- YI $8.44
- CNTB $0.95
- Average True Range (ATR)
- YI 0.50
- CNTB 0.08
- MACD
- YI -0.01
- CNTB -0.01
- Stochastic Oscillator
- YI 78.83
- CNTB 0.00
About YI 111 Inc.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.